Photo from wikipedia
Although the benefits of albuterol delivered via metered‐dose inhalers with a spacer (MDI+S) have been increasingly recognized, the evidence regarding the cost‐effectiveness of MDI+S compared to nebulization (NEB) is not… Click to show full abstract
Although the benefits of albuterol delivered via metered‐dose inhalers with a spacer (MDI+S) have been increasingly recognized, the evidence regarding the cost‐effectiveness of MDI+S compared to nebulization (NEB) is not sufficient, especially in less‐affluent countries, where the clinical and economic burden of the disease is the greatest. The aim of the present study was to evaluate the cost‐effectiveness of MDI+S vs NEB for delivering albuterol for the treatment of pediatric asthma exacerbations.
Journal Title: Pediatric Pulmonology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!